BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) is expected to be announcing its Q1 2025 earnings results before the market opens on Friday, May 2nd. Analysts expect BrightSpring Health Services to post earnings of $0.14 per share and revenue of $2.74 billion for the quarter.
BrightSpring Health Services Trading Up 2.2 %
Shares of BTSG traded up $0.37 during trading hours on Friday, hitting $16.92. 844,044 shares of the stock traded hands, compared to its average volume of 1,288,847. The business has a fifty day moving average of $17.80 and a 200-day moving average of $18.42. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The firm has a market capitalization of $2.96 billion, a PE ratio of -65.08 and a beta of 2.02. BrightSpring Health Services has a 1-year low of $10.15 and a 1-year high of $24.82.
Analysts Set New Price Targets
Separately, UBS Group increased their price objective on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. One research analyst has rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, BrightSpring Health Services presently has a consensus rating of "Moderate Buy" and an average target price of $21.67.
Check Out Our Latest Report on BTSG
About BrightSpring Health Services
(
Get Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Read More
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
